SYNACT — SynAct Pharma AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for SynAct Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	24	108	62.4	61.2	53.4
Net Total Receivables	10.7	14.7	12.4	14.4	13.4
Prepaid Expenses
Total Other Current Assets
Total Current Assets	34.9	140	75.1	94	71.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.18	2.1	0.66	1.94	1.21
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	38.4	143	228	271	221
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15.4	15	24.9	28.5	21.5
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	17.5	16.1	51.8	56.4	50.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	20.9	127	176	214	170
Total Liabilities & Shareholders' Equity	38.4	143	228	271	221
Total Common Shares Outstanding